Disc Medicine Statistics
Total Valuation
Disc Medicine has a market cap or net worth of $1.68 billion. The enterprise value is $1.25 billion.
Important Dates
The next estimated earnings date is Thursday, May 8, 2025, before market open.
| Earnings Date | May 8, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Disc Medicine has 34.57 million shares outstanding. The number of shares has increased by 23.71% in one year.
| Current Share Class | 34.57M |
| Shares Outstanding | 34.57M |
| Shares Change (YoY) | +23.71% |
| Shares Change (QoQ) | +0.20% |
| Owned by Insiders (%) | 1.27% |
| Owned by Institutions (%) | 65.11% |
| Float | 26.31M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 3.53 |
| P/TBV Ratio | 3.86 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 21.17, with a Debt / Equity ratio of 0.07.
| Current Ratio | 21.17 |
| Quick Ratio | 21.01 |
| Debt / Equity | 0.07 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -226.78 |
Financial Efficiency
Return on equity (ROE) is -27.73% and return on invested capital (ROIC) is -19.75%.
| Return on Equity (ROE) | -27.73% |
| Return on Assets (ROA) | -18.75% |
| Return on Invested Capital (ROIC) | -19.75% |
| Return on Capital Employed (ROCE) | -27.40% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.30M |
| Employee Count | 84 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Disc Medicine has paid $355,000 in taxes.
| Income Tax | 355,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -13.47% in the last 52 weeks. The beta is 2.85, so Disc Medicine's price volatility has been higher than the market average.
| Beta (5Y) | 2.85 |
| 52-Week Price Change | -13.47% |
| 50-Day Moving Average | 54.75 |
| 200-Day Moving Average | 52.76 |
| Relative Strength Index (RSI) | 43.50 |
| Average Volume (20 Days) | 355,535 |
Short Selling Information
The latest short interest is 2.24 million, so 6.47% of the outstanding shares have been sold short.
| Short Interest | 2.24M |
| Short Previous Month | 2.32M |
| Short % of Shares Out | 6.47% |
| Short % of Float | 8.50% |
| Short Ratio (days to cover) | 6.57 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -129.72M |
| Pretax Income | -90.89M |
| Net Income | -109.36M |
| EBITDA | -129.56M |
| EBIT | -129.72M |
| Earnings Per Share (EPS) | -$3.96 |
Full Income StatementBalance Sheet
The company has $489.88 million in cash and $30.00 million in debt, giving a net cash position of $459.88 million or $13.30 per share.
| Cash & Cash Equivalents | 489.88M |
| Total Debt | 30.00M |
| Net Cash | 459.88M |
| Net Cash Per Share | $13.30 |
| Equity (Book Value) | 443.59M |
| Book Value Per Share | 14.85 |
| Working Capital | 470.30M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$93.93 million and capital expenditures -$505,000, giving a free cash flow of -$94.43 million.
| Operating Cash Flow | -93.93M |
| Capital Expenditures | -505,000 |
| Free Cash Flow | -94.43M |
| FCF Per Share | -$2.73 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |